
无数据
无数据
无数据
| CAS Number | 1104-22-9 |
| Catalog Number | AG007D85(AGN-PC-0P0NHH) |
| Chemical Name | Meclizine DiHCl |
| EC Number | 214-164-8 |
| IUPAC Name | 1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;dihydrochloride |
| InChI | InChI=1S/C25H27ClN2.2ClH/c1-20-6-5-7-21(18-20)19-27-14-16-28(17-15-27)25(22-8-3-2-4-9-22)23-10-12-24(26)13-11-23;;/h2-13,18,25H,14-17,19H2,1H3;2*1H |
| InChI Key | VCTHNOIYJIXQLV-UHFFFAOYSA-N |
| MDL Number | MFCD00058199 |
| Molecular Formula | C25H29Cl3N2 |
| Molecular Weight | 463.8702 |
| SMILES | CC1=CC(CN2CCN(C(C3=CC=C(Cl)C=C3)C4=CC=CC=C4)CC2)=CC=C1.[H]Cl.[H]Cl |
| Synonyms | Agyrax,
Antivert,
Bonamine,
Bonine,
Chiclida,
D Vert,
D-Vert,
Dihydrochloride, Meclizine,
DVert,
Histametizyn,
Hydrochloride, Meclizine,
Meclizine,
Meclizine Dihydrochloride,
Meclizine Hydrochloride,
Meclizine Monohydrochloride,
Meclozine,
Monohydrochloride, Meclizine,
Parachloramine,
Ru Vert M,
Ru-Vert-M,
Meclizine dihydrochloride,
1104-22-9,
Meclozine dihydrochloride,
Bonamine,
Meclizine hydrochloride,
Postafen,
Vertizine,
Taizer,
1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine dihydrochloride,
V-Cline,
Diadril,
Duremesin,
Ancolan dihydrochloride,
Postafene dihydrochloride,
meclizine diHCl,
Meclizine (dihydrochloride),
NSC 28728,
Parachloramine dihydrochloride,
Meclizine hydrochloride anhydrous,
meclizinedi hydrochloride,
EINECS 214-164-8,
UNII-V5604WJ3XP,
UNII-408UZ554UD,
V5604WJ3XP,
408UZ554UD,
1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine dihydrochloride,
1-p-Chlorbenzhydryl-m-methylbenzylpiperazine dihydrochloride,
DSSTox_CID_25348,
DSSTox_RID_80816,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-, dihydrochloride,
DSSTox_GSID_45348,
Meclizine 2HCl,
1-(4-Chlorobenzhydryl)-4-(3-methylbenzyl)piperazine Dihydrochloride,
1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine dihydrochloride,
Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl)-, dihydrochloride,
Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-, dihydrochloride,
SR-01000000274,
1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;dihydrochloride,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-, hydrochloride (1:2),
Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-, hydrochloride (1:2),
Prestwick_534,
ancolandihydrochloride,
meclizine-dihydrochloride,
NCGC00016563-01,
CAS-1104-22-9,
AC1L21SH,
AC1Q3A7M,
C25H27ClN2.2HCl,
SPECTRUM1500376,
C25H29Cl3N2,
(+-)-meclizine dihydrochloride,
SCHEMBL2193375,
CHEMBL1324020,
DTXSID9045348,
CTK8E8265,
KS-00000GIY,
HMS1569K16,
HMS1920J17,
Meclizine Hydrochloride (anhydrous),
BCP02929,
HY-B0349,
Tox21_110497,
CCG-38908,
MFCD00058199,
s1986,
AKOS015891690,
Tox21_110497_1,
BCP9000902,
CS-2388,
MCULE-6706083805,
NE58451,
Meclizine hydrochloride anhydrous, (+)-,
Meclizine hydrochloride anhydrous, (-)-,
NCGC00018296-07,
NCGC00094712-01,
NCGC00094712-02,
AC-28134,
AK-54924,
AN-48505,
BR-54924,
DS-14608,
BCP0726000289,
Meclizine dihydrochloride anhydrous, (+)-,
Meclizine dihydrochloride anhydrous, (-)-,
Meclozine dihydrochloride anhydrous, (+)-,
Meclozine dihydrochloride anhydrous, (-)-,
AB0004700,
AB2000406,
LS-111207,
TR-002148,
FT-0603544,
M2755,
ST24026804,
W0051,
EN300-71543,
104M229,
J-002420,
Q-201344,
SR-01000000274-3,
1-p-chlorbenzhydryl-m-methylbenzylpiperazinedihydrochloride,
1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-piperazindih,
1-(p-chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl)-piperazindihydrochlorid,
1-[(4-Chlorophenyl)phenyl- methyl]-4-[3-methylphenyl)- methyl]piperazine,
1-[(4-Chlorophenyl)phenyl-methyl]-4-[3-methylphenyl)-methyl]piperazine,
1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-piperazindihyd,
1-([4-chlorophenyl]phenylmethyl)-4-([3-methylphenyl]-methyl)piperazine dihydrochloride,
1-[(4-chlorophenyl)-phenyl-methyl]-4-(m-tolylmethyl)piperazine dihydrochloride,
1-[(4-Chlorophenyl)phenylmethyl]4-[(3-methylphenyl)methyl]piperazine dihydrochloride,
163837-33-0,
163837-34-1,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-, dihydrochloride, (+)-,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-, dihydrochloride, (-)-,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-, hydrochloride (1:2), (+)-,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-, hydrochloride (1:2),(-)-,
meclizine,
Meclizine Hcl,
Navidoxine,
Antivert,
null,
Meclozine,
UNII-L997QXC9J1,
C25H27ClN2.2ClH,
L997QXC9J1,
C25-H27-Cl-N2.2Cl-H,
CID64713,
Meclizine dihydrochloride, 99% - 25G 25g,
31884-77-2,
Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)-, dihydrochloride,
Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)-, monohydrochloride,
Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-, monohydrochloride,
|
| Complexity | 448 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 3 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 462.14g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 30 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 463.871g/mol |
| Monoisotopic Mass | 462.14g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 6.5A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

